There are currently no approved treatments or vaccines specifically for COVID-19, the respiratory disease that has killed more than 35,000 people and infected over 745,000 globally.
Health authorities in Democratic Republic of Congo said on Saturday that they plan to introduce a second Ebola vaccine, manufactured by Johnson & Johnson, to counter the second-worst outbreak of the virus in history.
Johnson & Johnson plans to seek a buyer for its medical device maker business, Cordis Corp, The Wall Street Journal reported citing people familiar with the matter.